{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:21:37Z","timestamp":1786371697923,"version":"build-2736575974"},"reference-count":165,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>COPD complicated by pulmonary aspergillosis (COPD-PA) encompasses invasive, chronic, and allergic phenotypes and is increasingly recognized as a high-burden comorbidity. Clinical recognition is often hindered by nonspecific manifestations, corticosteroid-suppressed inflammatory signs, and the suboptimal performance of serum galactomannan in non-neutropenic hosts. To define the translational utility of immune biomarkers in this population, evidence was synthesized from international guidelines and contemporary studies in COPD-enriched cohorts, and performance was appraised across diagnostic, monitoring, and prognostic domains. Convergent findings indicate that bronchoalveolar-lavage galactomannan facilitates early diagnosis; serum galactomannan indices stratify risk during exacerbations; Aspergillus-specific IgG supports rule-in for invasive and chronic disease; and pentraxin-3 adds prognostic information. Cytokines central to COPD-PA pathobiology, including interleukin-1\u03b2, interleukin-6, interleukin-8, and interleukin-17, provide adjunctive diagnostic value, whereas (1\u21923)-\u03b2-D-glucan shows limited specificity. On this basis, a three-tier framework was developed that classifies biomarkers as clinically validated, mechanistically promising, or exploratory, and this framework was translated into subtype-tailored panels and decision rules that favor either-positive criteria for screening and both-positive criteria for confirmation. It is concluded that immune biomarkers complement microbiology and imaging, expand access when bronchoscopy or biopsy is not feasible, and enable longitudinal risk stratification. Priorities include COPD-specific thresholds, assay standardization, and multicenter validation, with particular emphasis on chronic pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Biomarker-guided immunomodulation may benefit selected phenotypes but requires rigorous evaluation before clinical adoption.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1687790","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:37:37Z","timestamp":1761197857000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune markers for pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a narrative review"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuke","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect diseases: an Off Publ Infect Dis Soc America"},{"key":"B2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2400061","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal","year":"2024","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12890-020-01259-8","article-title":"The global impact of aspergillus infection on COPD","volume":"20","author":"Hammond","year":"2020","journal-title":"BMC pulmonary Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106720","article-title":"Mortality outcomes associated with invasive aspergillosis among acute exacerbation of chronic obstructive pulmonary disease patient population","volume":"191","author":"Mir","year":"2022","journal-title":"Respir Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2002050","DOI":"10.1183\/13993003.02050-2020","article-title":"A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD","volume":"57","author":"Tiew","year":"2021","journal-title":"Eur Respir J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2200507","DOI":"10.1183\/13993003.00507-2022","article-title":"Sensitisation to recombinant aspergillus fumigatus allergens and clinical outcomes in COPD","volume":"61","author":"Tiew","year":"2023","journal-title":"Eur Respir J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12931-021-01771-3","article-title":"A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"22","author":"Gu","year":"2021","journal-title":"Respir Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13585","article-title":"Aspergillus infection in chronic obstructive pulmonary diseases","volume":"17","author":"Guo","year":"2023","journal-title":"Clin Respir J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1183\/09031936.00062206","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"30","author":"Bulpa","year":"2007","journal-title":"Eur Respir J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol infection: Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13054-024-05073-0","article-title":"Septic shock in the immunocompromised cancer patient: A narrative review","volume":"28","author":"Nates","year":"2024","journal-title":"Crit Care (London England)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.02122.x","article-title":"Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis","volume":"15","author":"Cordonnier","year":"2009","journal-title":"Clin Microbiol infection: Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0294524","DOI":"10.1128\/spectrum.02945-24","article-title":"Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients","volume":"13","author":"Sun","year":"2025","journal-title":"Microbiol Spectr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112147-20231228-00399","article-title":"Expert consensus on the diagnosis and treatment of pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"47","year":"2024","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1294971","article-title":"Improved diagnostic markers for invasive pulmonary aspergillosis in copd patients","volume":"14","author":"Long","year":"2024","journal-title":"Front Cell infection Microbiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cmi.2023.02.002","article-title":"The clinical value of aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis","volume":"29","author":"Lu","year":"2023","journal-title":"Clin Microbiol infection"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109939","article-title":"Epithelial uptake leads to fungal killing in vivo and is aberrant in copd-derived epithelial cells","volume":"27","author":"Bertuzzi","year":"2024","journal-title":"iScience"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01041","article-title":"Bronchial epithelial cells on the front line to fight lung infection-causing aspergillus fumigatus","volume":"11","author":"Bigot","year":"2020","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41392-024-01881-6","article-title":"DNA of neutrophil extracellular traps promote NF-\u03baB-dependent autoimmunity via cGAS\/TLR9 in chronic obstructive pulmonary disease","volume":"9","author":"Chen","year":"2024","journal-title":"Signal transduction targeted Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S478568","article-title":"Inflammatory and immune mechanisms in COPD: current status and therapeutic prospects","volume":"17","author":"Qi","year":"2024","journal-title":"J Inflammation Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1404615","article-title":"Inflammation mechanism and research progress of COPD","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1201658","article-title":"Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD","volume":"14","author":"Raby","year":"2023","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12890-021-01427-4","article-title":"Clinical features and prognostic analysis of patients with aspergillus isolation during acute exacerbation of chronic obstructive pulmonary disease","volume":"21","author":"Gu","year":"2021","journal-title":"BMC pulmonary Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.rmr.2025.02.061","article-title":"Impact of specialized pro-resolving lipid mediators on the colonization of CF respiratory epithelia by aspergillus fumigatus","volume":"42","author":"Sy","year":"2025","journal-title":"Rev Des Maladies Respiratoires"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-023-12952-z","article-title":"Aspergillus fumigatus escape mechanisms from its harsh survival environments","volume":"108","author":"Liu","year":"2024","journal-title":"Appl Microbiol Biotechnol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00813-19","article-title":"Aspergillus fumigatus cell wall promotes apical airway epithelial recruitment of human neutrophils","volume":"88","author":"Feldman","year":"2020","journal-title":"Infection Immun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15699","DOI":"10.1038\/s41598-018-33902-0","article-title":"Human bronchial epithelial cells inhibit aspergillus fumigatus germination of extracellular conidia via flea recognition","volume":"8","author":"Richard","year":"2018","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(21)00511-7","article-title":"Global, Regional, and National Prevalence of, and Risk Factors for, Chronic Obstructive Pulmonary Disease (COPD) in 2019: A Systematic Review and Modelling Analysis","volume":"10","author":"Adeloye","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00174.2015","article-title":"Cigarette smoke-induced necroptosis and damp release trigger neutrophilic airway inflammation in mice","volume":"310","author":"Pouwels","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"Damps and damp-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"Damp-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12931-024-03092-7","article-title":"Aspergillus fumigatus is responsible for inflammation in a murine model of chronic obstructive pulmonary disease exacerbation","volume":"26","author":"Bouyssi","year":"2025","journal-title":"Respir Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"14473","DOI":"10.1038\/s41598-020-71367-2","article-title":"In vitro study on aspects of molecular mechanisms underlying invasive aspergillosis caused by gliotoxin and fumagillin, alone and in combination","volume":"10","author":"Gayathri","year":"2020","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"L298","DOI":"10.1152\/ajplung.00154.2017","article-title":"Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease","volume":"314","author":"Haw","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S249131","article-title":"The role of toll-like receptors 2 and 4 in the pathogenesis of chronic obstructive pulmonary disease","volume":"15","author":"Sidletskaya","year":"2020","journal-title":"Int J chronic obstructive pulmonary Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108445","article-title":"HSP60 regulates the cigarette smoke-induced activation of TLR4-NF-\u03baB-myD88 signalling pathway and NLRP3 inflammasome","volume":"103","author":"Ou","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2016.10.01","article-title":"The role of dectin-1\/raf-1 signal cascade in innate immune of human corneal epithelial cells against aspergillus fumigatus infection","volume":"9","author":"Zhao","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.12.7406","article-title":"TLRs govern neutrophil activity in aspergillosis","volume":"173","author":"Bellocchio","year":"2004","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B40","article-title":"The adaptor protein CARD9, from fungal immunity to tumorigenesis","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2018.09.006","article-title":"Aspergillus fumigatus conidia stimulate lung epithelial cells (TC-1 JHU-1) to produce IL-12, IFN\u03b3, IL-13 and IL-17 cytokines: modulatory effect of propolis extract","volume":"28","author":"Khosravi","year":"2018","journal-title":"J mycologie medicale"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.025528","article-title":"AP-1 activated by toll-like receptors regulates expression of IL-23 P19","volume":"284","author":"Liu","year":"2009","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2400021","article-title":"Glucocorticoids suppress NF-\u03bab-mediated neutrophil control of aspergillus fumigatus hyphal growth","volume":"213","author":"Thrikawala","year":"2024","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/qco.0000000000000381","article-title":"Immune responses to invasive aspergillosis: new understanding and therapeutic opportunities","volume":"30","author":"Hohl","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-023-00361-y","article-title":"Soluble epoxide hydrolase deficiency attenuates airway inflammation in COPD via IRE1\u03b1\/JNK\/AP-1 signaling pathway","volume":"20","author":"Yu","year":"2023","journal-title":"J Inflammation (London England)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108956","article-title":"Constitutive immune activity promotes JNK- and foxO-dependent remodeling of drosophila airways","volume":"35","author":"Wagner","year":"2021","journal-title":"Cell Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/s41598-023-28567-3","article-title":"Involvement of JNK signaling in aspergillus fumigatus-induced inflammatory factors release in bronchial epithelial cells","volume":"13","author":"Cui","year":"2023","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/jof8050480","article-title":"Clinical aspergillus signatures in COPD and bronchiectasis","volume":"8","author":"Tiew","year":"2022","journal-title":"J fungi (Basel Switzerland)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05397.x","article-title":"The immune response to fungal infections","volume":"129","author":"Shoham","year":"2005","journal-title":"Br J haematology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-022-01960-2","article-title":"The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease","volume":"51","author":"Otu","year":"2023","journal-title":"Infection"},{"key":"B52","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/antiox14070839","article-title":"Oxidative stress and inflammation in hypoxemic respiratory diseases and their comorbidities: molecular insights and diagnostic advances in chronic obstructive pulmonary disease and sleep apnea","volume":"14","author":"Rodr\u00edguez-P\u00e9rez","year":"2025","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1802244","DOI":"10.1183\/13993003.02244-2018","article-title":"Defective bacterial phagocytosis is associated with dysfunctional mitochondria in copd macrophages","volume":"54","author":"Belchamber","year":"2019","journal-title":"Eur Respir J"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1177\/17534666241308408","article-title":"Advances in acute COPD exacerbation: clarifying specific immune mechanisms of infectious and noninfectious factors","volume":"19","author":"Tu","year":"2025","journal-title":"Ther Adv Respir Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0351LE","article-title":"Reduced clearance of fungal spores by chronic obstructive pulmonary disease GM-CSF- and M-CSF-derived macrophages","volume":"58","author":"Wrench","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"PA4657","DOI":"10.1183\/13993003.congress-2016.PA4657","article-title":"Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages","volume":"48","author":"Belchamber","year":"2016","journal-title":"Eur Respir J"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00140-18","article-title":"Aspergillus fumigatus and aspergillosis in 2019","volume":"33","author":"Latg\u00e9","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.1038\/s41467-024-51047-9","article-title":"Interplay between host humoral pattern recognition molecules controls undue immune responses against aspergillus fumigatus","volume":"15","author":"Delli\u00e8re","year":"2024","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00823","article-title":"Pentraxin 3 in cardiovascular disease","volume":"10","author":"Ristagno","year":"2019","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.3390\/ijms25115631","article-title":"Macrophage polarization and functions in pathogenesis of chronic obstructive pulmonary disease","volume":"25","author":"Kim","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.3390\/ijms20112785","article-title":"Chemokines in COPD: from implication to therapeutic use","volume":"20","author":"Henrot","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03768-z","article-title":"Regulatory mechanisms of neutrophil migration from the circulation to the airspace","volume":"78","author":"Lin","year":"2021","journal-title":"Cell Mol Life sciences: CMLS"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1134\/s0022093021030017","article-title":"Molecular mechanisms for regulation of neutrophil apoptosis under normal and pathological conditions","volume":"57","author":"Noseykina","year":"2021","journal-title":"J evolutionary Biochem Physiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2023.2172264","article-title":"Pathogenicity and virulence of aspergillus fumigatus","volume":"14","author":"Earle","year":"2023","journal-title":"Virulence"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.977493","article-title":"Neutrophil extracellular traps in fungal infections: A seesaw battle in hosts","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"210241","DOI":"10.1183\/16000617.0241-2021","article-title":"Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy","volume":"31","author":"Keir","year":"2022","journal-title":"Eur Respir review: an Off J Eur Respir Soc"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/biom11081065","article-title":"Neutrophil elastase and chronic lung disease","volume":"11","author":"Voynow","year":"2021","journal-title":"Biomolecules"},{"key":"B69","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev-immunol-083122-040624","article-title":"Bidirectional communication between the innate and adaptive immune systems","volume":"43","author":"Warrick","year":"2025","journal-title":"Annu Rev Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01133-1","article-title":"CD4(+) T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors","volume":"21","author":"Lei","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.905867","article-title":"T cell responses to control fungal infection in an immunological memory lens","volume":"13","author":"Sharma","year":"2022","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2010.10.005","article-title":"Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses","volume":"13","author":"Chai","year":"2011","journal-title":"Microbes infection"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.4110\/in.2023.23.e41","article-title":"The role of CD4 T cell help in CD8 T cell differentiation and function during chronic infection and cancer","volume":"23","author":"Topchyan","year":"2023","journal-title":"Immune network"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2021009","article-title":"The functions of CD4 T-helper lymphocytes in chronic obstructive pulmonary disease","volume":"54","author":"Qin","year":"2022","journal-title":"Acta Biochim Biophys Sin"},{"key":"B78","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.cyto.2018.05.019","article-title":"Emerging IL-12 family cytokines in the fight against fungal infections","volume":"111","author":"Thompson","year":"2018","journal-title":"Cytokine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2400386","DOI":"10.1183\/13993003.00386-2024","article-title":"Th2-skewed peripheral T-helper cells drive B-cells in allergic bronchopulmonary aspergillosis","volume":"63","author":"Luo","year":"2024","journal-title":"Eur Respir J"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2100569","DOI":"10.1183\/13993003.00569-2021","article-title":"An interferon-inducible signature of airway disease from blood gene expression profiling","volume":"59","author":"Yun","year":"2022","journal-title":"Eur Respir J"},{"key":"B81","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1183\/09031936.00162912","article-title":"Aspergillus fumigatus during stable state and exacerbations of COPD","volume":"43","author":"Bafadhel","year":"2014","journal-title":"Eur Respir J"},{"key":"B82","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/biology14040347","article-title":"The role of IL-23 in the development of inflammatory diseases","volume":"14","author":"Garc\u00eda-Dom\u00ednguez","year":"2025","journal-title":"Biology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01348-2","article-title":"Fungal sensing by dectin-1 directs the non-pathogenic polarization of T(H)17 cells through balanced type I IFN responses in human DCs","volume":"23","author":"Gringhuis","year":"2022","journal-title":"Nat Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3390\/pathogens11121547","article-title":"The double game played by Th17 cells in infection: host defense and immunopathology","volume":"11","author":"Paroli","year":"2022","journal-title":"Pathog (Basel Switzerland)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.3390\/ijms24054865","article-title":"Th17\/Treg imbalance: implications in lung inflammatory diseases","volume":"24","author":"Thomas","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.804919","article-title":"Th17\/Treg imbalance in chronic obstructive pulmonary disease: clinical and experimental evidence","volume":"12","author":"Louren\u00e7o","year":"2021","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000001183","article-title":"Th17 cells are involved in mouse chronic obstructive pulmonary disease complicated with invasive pulmonary aspergillosis","volume":"134","author":"Geng","year":"2020","journal-title":"Chin Med J"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100906","article-title":"Dectin-1 diversifies aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation","volume":"208","author":"Rivera","year":"2011","journal-title":"J Exp Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-014-0145-7","article-title":"Upregulation of IL-17A\/F from human lung tissue explants with cigarette smoke exposure: implications for COPD","volume":"15","author":"Chang","year":"2014","journal-title":"Respir Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.107","article-title":"Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi","volume":"7","author":"Bacher","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/jof3040055","article-title":"The multifaceted role of T-helper responses in host defense against aspergillus fumigatus","volume":"3","author":"Dewi","year":"2017","journal-title":"J fungi (Basel Switzerland)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1164\/rccm.201312-2293OC","article-title":"T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease","volume":"190","author":"Kalathil","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1402888","article-title":"IL-17 in plasma and bronchoalveolar lavage fluid in non-neutropenic patients with invasive pulmonary aspergillosis","volume":"14","author":"He","year":"2024","journal-title":"Front Cell infection Microbiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imr.12859","article-title":"The role of B cell antigen presentation in the initiation of cd4+ T cell response","volume":"296","author":"Hua","year":"2020","journal-title":"Immunol Rev"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17804","article-title":"Disrupted B-cell cytokine homeostasis in psoriasis: the impact of elevated IL-6 and impaired IL-10 production","volume":"52","author":"Kitano","year":"2025","journal-title":"J Dermatol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12931-022-02208-1","article-title":"IL-10 producing regulatory B cells are decreased in blood from smokers and copd patients","volume":"23","author":"Jacobs","year":"2022","journal-title":"Respir Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328348b159","article-title":"Immune responses against aspergillus fumigatus: what have we learned","volume":"24","author":"Cramer","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1177\/20499361241253751","article-title":"Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges","volume":"11","author":"Tashiro","year":"2024","journal-title":"Ther Adv Infect Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12931-025-03171-3","article-title":"High level of initial aspergillus fumigatus-specific IgE links increased risk of exacerbation in allergic bronchopulmonary aspergillosis patients","volume":"26","author":"Qian","year":"2025","journal-title":"Respir Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20221106-02333","article-title":"Clinical features and related factors of invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"103","author":"Zhang","year":"2023","journal-title":"Zhonghua yi xue za zhi"},{"key":"B102","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/s2213-2600(21)00138-7","article-title":"Covid-19-associated aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion","volume":"9","author":"van de Veerdonk","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/jof9020131","article-title":"Invasive pulmonary aspergillosis","volume":"9","author":"Ledoux","year":"2023","journal-title":"J fungi (Basel Switzerland)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol infection: Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/cc11443","article-title":"Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: A prospective study","volume":"16","author":"He","year":"2012","journal-title":"Crit Care (London England)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0366-6999.20131651","article-title":"Prognostic value of serum galactomannan index in critically ill patients with chronic obstructive pulmonary disease at risk of invasive pulmonary aspergillosis","volume":"127","author":"He","year":"2014","journal-title":"Chin Med J"},{"key":"B107","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof3020026","article-title":"Innate and adaptive immune defects in chronic pulmonary aspergillosis","volume":"3","author":"Bongomin","year":"2017","journal-title":"J fungi (Basel Switzerland)"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214484","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits","volume":"75","author":"Mathioudakis","year":"2020","journal-title":"Thorax"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1600791","DOI":"10.1183\/13993003.00791-2016","article-title":"Management of COPD exacerbations: A european respiratory society\/american thoracic society guideline","volume":"49","author":"Wedzicha","year":"2017","journal-title":"Eur Respir J"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect diseases: an Off Publ Infect Dis Soc America"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.02.019","article-title":"Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients","volume":"72","author":"Fort\u00fan","year":"2016","journal-title":"J infection"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3390\/mi14091740","article-title":"Bronchoalveolar lavage fluid from chronic obstructive pulmonary disease patients increases neutrophil chemotaxis measured by a microfluidic platform","volume":"14","author":"Ren","year":"2023","journal-title":"Micromachines"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02223","article-title":"Evaluation of galactomannan testing, the aspergillus-specific lateral-flow device test and levels of cytokines in bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis","volume":"9","author":"Salzer","year":"2018","journal-title":"Front Microbiol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12334","article-title":"Performance of serum galactomannan in patients with allergic bronchopulmonary aspergillosis","volume":"58","author":"Agarwal","year":"2015","journal-title":"Mycoses"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0198479","DOI":"10.1371\/journal.pone.0198479","article-title":"Utility of serum aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease","volume":"13","author":"Yoshimura","year":"2018","journal-title":"PloS One"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.03567-13","article-title":"Use and limits of (1-3)-\u03b2-D-glucan assay (Fungitell), compared to galactomannan determination (Platelia aspergillus), for diagnosis of invasive aspergillosis","volume":"52","author":"Sulahian","year":"2014","journal-title":"J Clin Microbiol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1186\/2049-6958-8-59","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"8","author":"Tutar","year":"2013","journal-title":"Multidiscip Respir Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e0327620","DOI":"10.1128\/jcm.03276-20","article-title":"Challenges with utilizing the 1,3-beta-D-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children","volume":"59","author":"Hsu","year":"2021","journal-title":"J Clin Microbiol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.62828","article-title":"Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests","volume":"30","author":"Gao","year":"2010","journal-title":"Ann Saudi Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"Supplement_2","DOI":"10.1093\/ofid\/ofac492.064","article-title":"871. Oral ibrexafungerp outcomes by fungal disease in patients from an interim analysis of a phase 3 open-label study (FURI)","volume":"9","author":"Thompson","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02429-19","article-title":"Combination therapy with ibrexafungerp (Formerly SCY-078), a first-in-class triterpenoid inhibitor of (1\u21923)-\u03b2-d-Glucan Synthesis, and isavuconazole for treatment of experimental invasive pulmonary aspergillosis","volume":"64","author":"Petraitis","year":"2020","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1599425","article-title":"Evaluation of a novel aspergillus IgG lateral flow assay for the diagnosis of non-neutropenic patients with acute and subacute invasive aspergillosis","volume":"15","author":"Lu","year":"2025","journal-title":"Front Cell infection Microbiol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13641","article-title":"Predictive factors for treatment response and mortality in chronic pulmonary aspergillosis","volume":"66","author":"Kosmidis","year":"2023","journal-title":"Mycoses"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1557241","article-title":"Clinical characteristics and risk factors analysis of allergic bronchopulmonary aspergillosis combined with bronchiectasis","volume":"12","author":"He","year":"2025","journal-title":"Front Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12890-018-0611-y","article-title":"Aspergillus fumigatus during COPD exacerbation: A pair-matched retrospective study","volume":"18","author":"Tong","year":"2018","journal-title":"BMC pulmonary Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cyto.2016.05.015","article-title":"New advances in invasive aspergillosis immunobiology leading the way towards personalized therapeutic approaches","volume":"84","author":"Obar","year":"2016","journal-title":"Cytokine"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.675294","article-title":"The IL-1 receptor is required to maintain neutrophil viability and function during aspergillus fumigatus airway infection","volume":"12","author":"Ralph","year":"2021","journal-title":"Front Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918507","article-title":"Cigarette smoke-induced gasdermin D activation in bronchoalveolar macrophages and bronchial epithelial cells dependently on nlrp3","volume":"13","author":"Huot-Marchand","year":"2022","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/jof7100842","article-title":"Chronic pulmonary aspergillosis: disease severity using image analysis and correlation with systemic proinflammation and predictors of clinical outcome","volume":"7","author":"Huang","year":"2021","journal-title":"J fungi (Basel Switzerland)"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8740491","article-title":"The serum level of IL-1B correlates with the activity of chronic pulmonary aspergillosis","volume":"2018","author":"Zhan","year":"2018","journal-title":"Can Respir J"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/srep26490","article-title":"Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the interleukin-1 receptor","volume":"6","author":"Gresnigt","year":"2016","journal-title":"Sci Rep"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2021-001857","article-title":"Diagnosis values of IL-6 and IL-8 levels in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in chronic obstructive pulmonary disease","volume":"69","author":"Liu","year":"2021","journal-title":"J Invest Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.2147\/idr.S403401","article-title":"Serum cytokine biomarkers for use in diagnosing pulmonary tuberculosis versus chronic pulmonary aspergillosis","volume":"16","author":"Ren","year":"2023","journal-title":"Infection Drug resistance"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115272","article-title":"Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: A case report","volume":"99","author":"Witting","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211855","article-title":"Biomarkers and clinical outcomes in COPD: A systematic review and meta-analysis","volume":"74","author":"Fermont","year":"2019","journal-title":"Thorax"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.106882","article-title":"Autopsy study of fatal invasive pulmonary aspergillosis: often undiagnosed premortem","volume":"199","author":"Mudrakola","year":"2022","journal-title":"Respir Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02422-7","article-title":"Characterizing CRP dynamics during acute infections","volume":"53","author":"Cherny","year":"2025","journal-title":"Infection"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1274634","article-title":"Structural insights into the biological functions of the long pentraxin PTX3","volume":"14","author":"Massimino","year":"2023","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1575968","article-title":"Advances in understanding the role of pentraxin-3 in lung infections","volume":"16","author":"Ma","year":"2025","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1128\/aac.48.11.4414-4421.2004","article-title":"Anti-aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals","volume":"48","author":"Gaziano","year":"2004","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1111\/all.16303","article-title":"Interleukin-5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: effects on and beyond eosinophils","volume":"79","author":"Buchheit","year":"2024","journal-title":"Allergy"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.754268","article-title":"Monoclonal antibodies targeting IL-5 or IL-5R\u03b1 in eosinophilic chronic obstructive pulmonary disease: A systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S438153","article-title":"Biological anti-IL-5\/IL-5R therapeutics for chronic obstructive pulmonary disease (COPD) with specific treatable traits: A real-world retrospective analysis","volume":"19","author":"Day de Larra\u00f1aga","year":"2024","journal-title":"Int J chronic obstructive pulmonary Dis"},{"key":"B144","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/17476348.2025.2517302","article-title":"New insights into the treatment of asthma complicated by allergic bronchopulmonary aspergillosis","volume":"19","author":"Agarwal","year":"2025","journal-title":"Expert Rev Respir Med"},{"key":"B145","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1038\/s41598-023-32246-8","article-title":"Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis","volume":"13","author":"Tomomatsu","year":"2023","journal-title":"Sci Rep"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00857-w","article-title":"What does elevated TARC\/CCL17 expression tell us about eosinophilic disorders","volume":"43","author":"Catherine","year":"2021","journal-title":"Semin immunopathology"},{"key":"B147","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/myc.13083","article-title":"Diagnostic markers of allergic bronchopulmonary aspergillosis in patients with severe asthma","volume":"63","author":"Kozlova","year":"2020","journal-title":"Mycoses"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2020.04.004","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) predicts decline of pulmonary function in patients with chronic obstructive pulmonary disease","volume":"70","author":"Machida","year":"2021","journal-title":"Allergology Int"},{"key":"B149","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13054-015-0811-2","article-title":"The ratio of Th17\/treg cells as a risk indicator in early acute respiratory distress syndrome","volume":"19","author":"Yu","year":"2015","journal-title":"Crit Care (London England)"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2019.01.041","article-title":"Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against candida albicans","volume":"176","author":"Bacher","year":"2019","journal-title":"Cell"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00604.2020","article-title":"Increased serum SP-D in identification of high-risk smokers at high risk of COPD","volume":"320","author":"Dalg\u00e5rd","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"92","DOI":"10.21037\/jtd-20-1675","article-title":"Lung function decline, and incident chronic obstructive pulmonary disease: A longitudinal study in beijing","volume":"13","author":"Liao","year":"2021","journal-title":"J Thorac Dis"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00060603","article-title":"Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis","volume":"22","author":"Krane","year":"2003","journal-title":"Eur Respir J"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1128\/iai.69.4.2728-2731.2001","article-title":"Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis","volume":"69","author":"Madan","year":"2001","journal-title":"Infection Immun"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab583","article-title":"Defective interferon-gamma production is common in chronic pulmonary aspergillosis","volume":"225","author":"Colombo","year":"2022","journal-title":"J Infect Dis"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw444","article-title":"Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect diseases: an Off Publ Infect Dis Soc America"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3390\/diagnostics12061364","article-title":"Cytokine profile of invasive pulmonary aspergillosis in severe covid-19 and possible therapeutic targets","volume":"12","author":"Russo","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2012.02283.x","article-title":"Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease: A single-centre retrospective analysis of 52 subjects","volume":"18","author":"Dai","year":"2013","journal-title":"Respirology (Carlton Vic)"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S51012","article-title":"Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease","volume":"9","author":"Woods","year":"2014","journal-title":"Int J chronic obstructive pulmonary Dis"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(24)00567-x","article-title":"Mortality in chronic pulmonary aspergillosis: A systematic review and individual patient data meta-analysis","volume":"25","author":"Sengupta","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(24)00225-0","article-title":"Paving the way for affordable and equitable liposomal amphotericin B access worldwide","volume":"12","author":"Lee","year":"2024","journal-title":"Lancet Global Health"},{"key":"B162","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00203-024-04026-z","article-title":"Azole resistance in aspergillus fumigatus- comprehensive review","volume":"206","author":"Dladla","year":"2024","journal-title":"Arch Microbiol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200312113492424","article-title":"False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam","volume":"349","author":"Sulahian","year":"2003","journal-title":"New Engl J Med"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.2147\/copd.s4229","article-title":"Management of invasive aspergillosis in patients with copd: rational use of voriconazole","volume":"4","author":"Ader","year":"2009","journal-title":"Int J chronic obstructive pulmonary Dis"},{"key":"B165","doi-asserted-by":"publisher","first-page":"e0060725","DOI":"10.1128\/spectrum.00607-25","article-title":"Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: A multicenter cohort study","volume":"13","author":"Wang","year":"2025","journal-title":"Microbiol Spectr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1687790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:37:40Z","timestamp":1761197860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1687790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":165,"alternative-id":["10.3389\/fimmu.2025.1687790"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1687790","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"article-number":"1687790"}}